← FDA DRUG APPROVALS

FDA ANDA · ANDA078380

SILDENAFIL CITRATE

Sponsor: TEVA PHARMS

APPLICATION
ANDA078380
TYPE
ANDA
ORIGINAL APPROVAL
2013-01-07
LATEST ACTION
2020-02-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

SILDENAFIL CITRATEDiscontinued
SILDENAFIL CITRATE EQ 20MG BASE · TABLET · ORAL

Approval history

2020-02-25Labeling · Supplement 9 · standardAP
2020-02-25Labeling · Supplement 7 · standardAP
2020-02-25Labeling · Supplement 6 · standardAP
2015-11-10Labeling · Supplement 3 · standardAP
2015-03-02Labeling · Supplement 1 · standardAP
2013-01-07OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →